epigenetics May 31, 2022 Cardio Diagnostics to Go Public via Merger With SPAC May 31, 2022 VolitionRx Gets CE Mark for NETosis Test Mar 31, 2022 New Esophageal Cancer Tests on Horizon as Hopkins Spinout Capsulomics Preps Clinical Launch Premium Jan 7, 2022 Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom Premium Nov 3, 2021 Genomic Answers for Kids Team Releases Thousands of Genomes to Gain Insights Into Rare Diseases Premium Sep 1, 2021 Burning Rock Details Plans for Cancer Monitoring Assay, Adds New Data Supporting Early Detection Premium Aug 31, 2021 Oxford BioDynamics Awarded Grant to Apply EpiSwitch to ICI Cancer Therapy Response Aug 27, 2021 Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech Premium Apr 16, 2021 OncoDiag Taking Aim at Broader Adoption of Molecular Multiplex Test for Bladder Cancer Recurrence Premium Apr 15, 2021 Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Mar 31, 2021 Delfi Diagnostics Starts Prospective Lung Cancer Screening Trial Mar 24, 2021 DARPA Programs Leveraging Host-Response Testing, CRISPR for Future Pandemic Preparedness Premium Jan 12, 2021 Delfi Diagnostics Details Plans to Advance Fragmentomic Method for Early Cancer Detection Premium Jan 12, 2021 Delfi Diagnostics Nets $100M in Series A Financing, Plans Multi-Cancer Screening Test Jan 11, 2021 Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021 Premium Jan 5, 2021 VolitionRx, 4D Lifetec Partner to Combine Early Cancer Detection Assays Sep 16, 2020 Illumina's Stock Falls 9 Percent on Grail Acquisition Rumors Jul 31, 2020 Data Supports Singlera's PanSeer Test as Company Narrows Focus to Colorectal Cancer Detection Jul 24, 2020 Norwegian Diagnostics Firm Age Labs to Develop Epigenetics-Based Test for SARS-CoV-2 Jul 1, 2020 AnchorDx Demonstrates Liquid Biopsy DNA Methylation Test for Early Cancer Detection Load More Breaking News European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal AnPac Bio to Raise $5M in Private Placement Top Five Articles on 360Dx Last Week: Sherlock Bio's $2M Award; Nostics' POC Testing Plans; and More KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure
